{Reference Type}: Journal Article
{Title}: An optimized 3T MRI scan protocol to assess iris melanoma with subsequent histopathological verification - A prospective study.
{Author}: Lim JZ;Gokul A;Misra SL;Pan X;Charlton A;McGhee CNJ;
{Journal}: Asia Pac J Ophthalmol (Phila)
{Volume}: 13
{Issue}: 2
{Year}: 2024 Mar-Apr 28
{Factor}: 4.206
{DOI}: 10.1016/j.apjo.2024.100047
{Abstract}: BACKGROUND: Magnetic resonance imaging (MRI) has demonstrated high levels of tissue contrast, accuracy and reproducibility in evaluating posterior uveal melanoma. Owing to smaller size, the role of MRI in detecting and characterising iris melanoma has not yet been explored.
OBJECTIVE: To develop a protocol to image iris melanoma and describe the MRI characteristics of histopathological-confirmed iris melanoma.
METHODS: An optimised MRI protocol, using a 3T MRI scanner and a 32-channel head coil, was developed to image iris tumours. A prospective, single-centre, 12-month study was conducted on all patients with lesions suspicious for iris melanoma. All patients were offered an MRI scan in addition to the standardised clinical procedures. Image quality comparison was made with existing clinical investigations. Iris melanoma characteristics on MRI are described.
RESULTS: A successful optimised MRI scan protocol was developed that was able to detect and characterise iris melanoma. One normal participant and five patients with subsequent histopathological-confirmed iris melanoma (n = 6) were recruited. Four patients completed the full MRI sequence. All iris melanoma were detected on at least one T1- or T2-weighted images. When compared to the vitreous, all iris melanomas demonstrated hyper-intensity on T1-weighted images and hypo-intensity on T2-weighted images. On T1-mapping, T1-values of iris melanoma demonstrated an inverse relationship with the degree of tumour pigmentation.
CONCLUSIONS: This study highlights an optimised, easily reproducible MRI scan protocol to image iris melanoma. Numerous MR imaging characteristics of iris melanoma are reported for the first time and a potential non-invasive tumour biomarker is described.